7Baggers
 hoth therapeutics' cancer, derm, neurology pipeline  BioXconomy Fri, 14 Nov 2025 11:23:38 GMT
 published on: 2025-11-02 11:43:45  newser.com Sun, 02 Nov 2025 16:43:45 GMT
 published on: 2025-10-30 00:33:14  newser.com Thu, 30 Oct 2025 05:33:14 GMT
 2 Stocks to Buy Under $10 That Wall Street Loves  Yahoo Finance Wed, 29 Oct 2025 07:00:00 GMT
 published on: 2025-10-28 22:41:09  newser.com Wed, 29 Oct 2025 03:41:09 GMT
 published on: 2025-10-27 23:37:27  newser.com Tue, 28 Oct 2025 04:37:27 GMT
 hoth therapeutics begins va-backed study for obesity treatment by investing.com  Investing.com Canada Tue, 28 Oct 2025 00:02:14 GMT
 Hoth therapeutics begins VA-backed study for obesity treatment  Investing.com Mon, 27 Oct 2025 07:00:00 GMT
 published on: 2025-10-26 13:16:28  newser.com Sun, 26 Oct 2025 18:16:28 GMT
 published on: 2025-10-25 16:22:11  newser.com Sat, 25 Oct 2025 21:22:11 GMT
 published on: 2025-10-24 13:43:36  newser.com Fri, 24 Oct 2025 18:43:36 GMT
 published on: 2025-10-24 11:09:15  newser.com Fri, 24 Oct 2025 16:09:15 GMT

Hoth Therapeutics, Inc
(NASDAQ:HOTH) 

HOTH stock logo

Hoth Therapeutics, Inc., a biopharmaceutical company, focuses on developing therapies for dermatological disorders. The company focuses on therapies for patients suffering from indications, including eczema, chronic wounds, psoriasis, asthma, and acne. Its pipeline portfolio includes HT-001, a topic...

Founded: 2017
Full Time Employees: 2
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends